tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
TipRanksTop Financial ExpertsInsidersAxel Bolte

Axel Bolte Insider Profile

11 Followers
Axel Bolte, Director at IVERIC bio, holds 0.00 shares in IVERIC bio (Ticker: ISEE), holds ― shares in Nabriva Therapeutics (Ticker: NBRVF), holds ― shares in Allena Pharmaceuticals (Ticker: ALNAQ).
See the Hottest Stocks Based on Insider Trading >
tipranks
Axel Bolte

Axel Bolte
IVERIC bio (ISEE)
Director

Ranked #28,640 out of 100,956 Corporate Insiders

Profitable Transactions

60%
3 out of 5 Profitable Transactions

Average Return

+7.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$1M
77.42%
22.58%
0.00%
A breakdown of Axel Bolte's holdings
See the Top Stocks by Insiders

Insider Roles

PTC Therapeutics
(PTCT)
Director
Inozyme Pharma
(INZY)
Director
Nabriva Therapeutics
(NBRVF)
Director
Roles that Axel Bolte holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Inozyme Pharma
(INZY)
Rating:Informative Sell
Date:Jun 25, 2021 - Jun 25, 2022
Return:+73.90%
The most profitable trade made by Axel Bolte
See the Latest Stocks Traded by Insiders

Axel Bolte's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ISEE
IVERIC bio
Jul 13, 2023
―
Uninformative Sell
―
$0.00
NBRVF
Nabriva Therapeutics
―
Director
―
―
ALNAQ
Allena Pharmaceuticals
―
―
―
―
INZY
Inozyme Pharma
Apr 04, 2023
Director
Uninformative Buy
10.62K
$306.70K
PTCT
PTC Therapeutics
Jun 27, 2013
Director
Informative Buy
300.00K
$1.05M
List of latest transactions for each holding click on a transaction to see Axel Bolte's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Axel Bolte insider profile FAQ

What is the percentage of profitable transactions made by Axel Bolte?
The percentage of profitable transactions made by Axel Bolte is 60%.
    What is the average return per transaction made by Axel Bolte?
    The average return per transaction made by Axel Bolte is 7.60%.
      What stocks does Axel Bolte hold?
      Axel Bolte holds: ISEE, NBRVF, ALNAQ, INZY, PTCT stocks.
        What was Axel Bolte’s latest transaction?
        Axel Bolte latest transaction was an Uninformative Sell of ―.
          What was Axel Bolte's most profitable transaction?
          Axel Bolte’s most profitable transaction was an Informative Sell of INZY stock on June 25, 2021. The return on the trade was 73.90%.
            What is Axel Bolte's role in IVERIC bio?
            Axel Bolte's role in IVERIC bio is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.